Cargando…
Shuangshen Ningxin capsule alleviates myocardial ischemia–reperfusion injury in miniature pigs by modulating mitophagy: network pharmacology and experiments in vivo
BACKGROUND: Myocardial ischemia/reperfusion injury (MI/RI) is involved in a variety of pathological states for which there is no effective treatment exists. Shuangshen Ningxin (SSNX) capsule which is developed by Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine has been demonstrated...
Autores principales: | Jia, Feifan, Chen, Yuanyuan, Xin, Gaojie, Li, Lingmei, Liu, Zixin, Xu, Sujuan, Gao, Jiaming, Meng, Hongxu, Shi, Yue, Ma, Yanlei, Li, Lei, Fu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510173/ https://www.ncbi.nlm.nih.gov/pubmed/37730607 http://dx.doi.org/10.1186/s13020-023-00810-z |
Ejemplares similares
-
Shuangshen Ningxin Capsule, a Traditional Chinese Medicinal Preparation, Alleviates Myocardial Ischemia through Autophagy Regulation
por: Wang, Jun, et al.
Publicado: (2015) -
Protective Effects of Shen-Yuan-Dan Capsule against Ischemia/Reperfusion Injury in Cardiomyocytes by Alleviating Endoplasmic Reticulum Stress
por: Tong, Tong, et al.
Publicado: (2022) -
Self-Designed Ningxin Anshen Formula for Treatment of Post-ischemic Stroke Insomnia: A Randomized Controlled Trial
por: Dai, Ning, et al.
Publicado: (2020) -
Prediction of Molecular Mechanisms for LianXia NingXin Formula: A Network Pharmacology Study
por: Yang, Yang, et al.
Publicado: (2018) -
Mitophagy alleviates ischemia/reperfusion-induced microvascular damage through improving mitochondrial quality control
por: Wu, Dan, et al.
Publicado: (2022)